<DOC>
	<DOCNO>NCT01970007</DOCNO>
	<brief_summary>The purpose VIVO Clinical Study evaluate safety effectiveness Zilver® Vena™ Venous Stent treatment symptomatic iliofemoral venous outflow obstruction .</brief_summary>
	<brief_title>VIVO Clinical Study</brief_title>
	<detailed_description />
	<criteria>symptomatic venous outflow obstruction one iliofemoral venous segment ( i.e. , one limb ) per patient , demonstrate : CEAP `` C '' ≥ 3 , VCSS pain score ≥ 2 &lt; 18 year age ; pregnant planning become pregnant next 12 month ; plan surgical interventional procedure target limb ( except thrombolysis and/or thrombectomy preparation procedure vena cava filter placement prior stent implantation patient high risk pulmonary embolism ) within 30 day prior time study procedure ; plan surgical interventional procedure medical condition ( i.e. , associate target limb ) within 30 day prior study procedure ; lesion intend treatment length extend inferior vena cava level lesser trochanter ; lesion malignant obstruction ; previous stenting target vessel ; iliofemoral venous segment unsuitable treatment available size study device .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>venous</keyword>
	<keyword>outflow obstruction</keyword>
	<keyword>iliofemoral vein</keyword>
</DOC>